Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Fisher

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Alzheimer Research|January 29, 2008
M1 muscarinic agonists target major hallmarks of Alzheimer's disease--an updateAbraham Fisher
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 16, 2008
Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseaseAbraham Fisher
Neuro-Degenerative Diseases|March 7, 2008
M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptorsAbraham Fisher
Journal of Neurochemistry|November 30, 2011
Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's diseaseAbraham Fisher
Handbook of Clinical Neurology|May 8, 2025
CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatmentAbraham Fisher, Allan I Levey
Neuro-Degenerative Diseases|March 23, 2016
PrefaceAbraham Fisher, Roger M Nitsch, Manfred Windisch
Brain : a Journal of Neurology|March 15, 2022
Reimagining cholinergic therapy for Alzheimer's diseaseEzio Giacobini, A Claudio Cuello, Abraham Fisher
Current Alzheimer Research|April 10, 2009
M1 agonists as a potential disease-modifying therapy for Alzheimer's diseaseAntonella Caccamo, Abraham Fisher, Frank M LaFerla
Neuro-Degenerative Diseases|April 15, 2010
PrefaceManfred Windisch, Roger Nitsch, Abraham Fisher, et al.
Neuro-Degenerative Diseases|March 7, 2008
The 8th International Conference on Alzheimer's and Parkinson's Diseases. PrefaceIsrael Hanin, Manfred Windisch, Werner Poewe, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Alzheimer Research|January 29, 2008
M1 muscarinic agonists target major hallmarks of Alzheimer's disease--an updateAbraham Fisher
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 16, 2008
Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseaseAbraham Fisher
Neuro-Degenerative Diseases|March 7, 2008
M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptorsAbraham Fisher
Journal of Neurochemistry|November 30, 2011
Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's diseaseAbraham Fisher
Handbook of Clinical Neurology|May 8, 2025
CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatmentAbraham Fisher, Allan I Levey
Neuro-Degenerative Diseases|March 23, 2016
PrefaceAbraham Fisher, Roger M Nitsch, Manfred Windisch
Brain : a Journal of Neurology|March 15, 2022
Reimagining cholinergic therapy for Alzheimer's diseaseEzio Giacobini, A Claudio Cuello, Abraham Fisher
Current Alzheimer Research|April 10, 2009
M1 agonists as a potential disease-modifying therapy for Alzheimer's diseaseAntonella Caccamo, Abraham Fisher, Frank M LaFerla
Neuro-Degenerative Diseases|April 15, 2010
PrefaceManfred Windisch, Roger Nitsch, Abraham Fisher, et al.
Neuro-Degenerative Diseases|March 7, 2008
The 8th International Conference on Alzheimer's and Parkinson's Diseases. PrefaceIsrael Hanin, Manfred Windisch, Werner Poewe, et al.
Pageof 3